-
Window-of-opportunity trial of olaparib and durvalumab before standard neoadjuvant chemotherapy for stage II/III triple-negative or ER-low breast cancer (MEDIOLA WOO): whole-exome and transcriptome profiling of serial tumor biopsies
Study
EGAS50000002019
-
A Phase 2 Study of Lamivudine in Patients with p53 Mutant Metastatic Colorectal Cancer
Study
phs002833
-
Spatiotemporal single-cell analysis reveals a time-dependent immunological modulation by multi-fractionated radiotherapy in esophageal cancer
Study
JGAS000712
-
Epigenetic profiling of colorectal cancer initiating cells (CC-ICs) to identify bivalently marked genes (H3K4me3 and H3K27me3 ChIP-seq), and investigation of changes in transcriptome following EZH2 inhibition using RNA-seq.
Study
EGAS00001003003
-
Transcriptional Profiling of Macrophages In Situ in Metastatic Melanoma Reveals Localization-Dependent Phenotypes and Function
Study
phs002564
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Development of the prevention and therapy of CRC using patient derived culture tissues.
Study
JGAS000139
-
single cell RNA-seq of small cell lung cancer circulating tumor cells
Study
EGAS50000001401
-
RNA-seq TPMs quantification for baseline tumor samples originating from IMpower150, and relevant clinical metadata
Dataset
EGAD50000001814
-
ScRNA-seq of 6 human FL
Dataset
EGAD00001007691